Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Azithromycin Pharmacokinetics and Pharmacodynamics

Tissue Distribution and Concentration

  • The Centers for Disease Control and Prevention recommends azithromycin due to its high tissue distribution, with tissue-to-plasma concentration ratios of:

Clinical Implications

  • The CDC suggests that azithromycin is effective in a single 1g dose for infections such as chlamydia 2
  • The CDC notes that common side effects of azithromycin include gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea) 1
  • The CDC advises caution when administering azithromycin with drugs metabolized by the cytochrome P450 enzyme system 1
  • The FDA classifies azithromycin as a category B drug in pregnancy, according to the CDC 1